(-0.87%) 5 027.40 points
(-1.27%) 37 971 points
(-1.28%) 15 512 points
(-0.30%) $82.56
(-0.18%) $1.650
(0.00%) $2 338.50
(-0.06%) $27.33
(0.32%) $918.75
(-0.19%) $0.933
(0.05%) $10.99
(-0.28%) $0.800
(-0.09%) $92.24
Live Chart Being Loaded With Signals
Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally...
Stats | |
---|---|
Today's Volume | 295 253 |
Average Volume | 1.22M |
Market Cap | 3.58M |
EPS | £0 ( 2023-12-07 ) |
Last Dividend | £0 ( N/A ) |
Next Dividend | £0 ( N/A ) |
P/E | -0.420 |
ATR14 | £0.100 (2.86%) |
Fusion Antibodies PLC Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Fusion Antibodies PLC Financials
Annual | 2022 |
Revenue: | £2.90M |
Gross Profit: | £202 000 (6.96 %) |
EPS: | £-0.0998 |
Q2 | 2023 |
Revenue: | £541 000 |
Gross Profit: | £-209 000 (-38.63 %) |
EPS: | £-0.0292 |
Q4 | 2022 |
Revenue: | £1.04M |
Gross Profit: | £-157 000 (-15.13 %) |
EPS: | £-0.0569 |
Q3 | 2022 |
Revenue: | £519 000 |
Gross Profit: | £-16 500.00 (-3.18 %) |
EPS: | £-0.0284 |
Financial Reports:
No articles found.
Fusion Antibodies PLC
Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. It offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services. The company serves pharmaceutical, biotech, and diagnostic companies. It has a collaboration partnership with Celonic AG. Fusion Antibodies plc was incorporated in 2000 and is headquartered in Belfast, the United Kingdom.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators